Clinical Trial Update: Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the neuroprotective and symptomatic effects of silymarin in Parkinson's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Silymarin (silymarin)

Snippet

Sponsor: Tanta University | Conditions: Parkinson Disease | Phase 2 | Status: RECRUITING